Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-582-3p


Loading... Please wait, this might take a few seconds...



Filters
Clear all
Interactions: 376, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
QSER1 hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr11:32932929-32932957 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RNF4 hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr4:2514539-2514563 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SLC12A2 hsa-miR-582-3p low: 0 high: 1 1 1 1 0.470
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr5:128174638-128174653 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CDK13 hsa-miR-582-3p low: 0 high: 1 1 1 1 0.696
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr7:40094626-40094648 PAR-CLIP POSITIVE DIRECT TarBase 7.0
MTHFD2 hsa-miR-582-3p low: 0 high: 1 1 1 1 0.743
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr2:74214518-74214544 PAR-CLIP POSITIVE DIRECT TarBase 7.0
SMARCD1 hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr12:50090225-50090251 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PKM hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr15:72199171-72199188 PAR-CLIP POSITIVE DIRECT TarBase 7.0
CDC42 hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr1:22091692-22091710 PAR-CLIP POSITIVE DIRECT TarBase 7.0
TFRC hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr3:196051743-196051765 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TIMM21 hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr18:74148923-74148929 HITS-CLIP POSITIVE DIRECT TarBase 7.0
FNDC3B hsa-miR-582-3p low: 0 high: 1 1 1 1 0.529
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr3:172397998-172398013 HITS-CLIP POSITIVE DIRECT TarBase 7.0
BAZ2A hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr12:56598043-56598052 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TRAF4 hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr17:28747801-28747823 PAR-CLIP POSITIVE DIRECT TarBase 7.0
TM9SF3 hsa-miR-582-3p low: 0 high: 1 1 1 1 0.504
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr10:96519254-96519278 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ITCH hsa-miR-582-3p low: 0 high: 1 1 1 1 0.507
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr20:34508800-34508812 PAR-CLIP POSITIVE DIRECT TarBase 7.0
RAB21 hsa-miR-582-3p low: 0 high: 1 1 1 1 0.659
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr12:71790130-71790158 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PHLPP1 hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr18:62919992-62920010 PAR-CLIP POSITIVE DIRECT TarBase 7.0
GSK3B hsa-miR-582-3p low: 0 high: 1 1 1 1 0.898
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr3:119826746-119826765 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TNPO1 hsa-miR-582-3p low: 0 high: 1 1 1 1 0.670
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr5:72912412-72912427 HITS-CLIP POSITIVE DIRECT TarBase 7.0
FAT1 hsa-miR-582-3p low: 0 high: 1 1 1 1 0.486
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr4:186708549-186708577 HITS-CLIP POSITIVE DIRECT TarBase 7.0